BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3554800)

  • 1. [Controlled study of increasing venous tone in primary varicose veins by oral administration of Ruscus aculeatus and trimethylhespiridinchalcone].
    Weindorf N; Schultz-Ehrenburg U
    Z Hautkr; 1987 Jan; 62(1):28-38. PubMed ID: 3554800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Varicose vein drugs--new attempts at objectivation of the effects of therapy].
    Marshall M
    Fortschr Med; 1984 Aug; 102(29-30):772-4. PubMed ID: 6500447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improving venous tone and capillary sealing. Effect of a combination of Ruscus extract and hesperidine methyl chalcone in healthy probands in heat stress].
    Rudofsky G
    Fortschr Med; 1989 Jun; 107(19):52, 55-8. PubMed ID: 2668140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of extract of Ruscus aculeatus in venous disease in the lower limbs.
    Cappelli R; Nicora M; Di Perri T
    Drugs Exp Clin Res; 1988; 14(4):277-83. PubMed ID: 3048951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a drug combination on venous capacity].
    Rudofsky G; Nobbe F
    Fortschr Med; 1982 Jul; 100(25):1217-20. PubMed ID: 7106687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.
    Aguilar Peralta GR; Arévalo Gardoqui J; Llamas Macías FJ; Navarro Ceja VH; Mendoza Cisneros SA; Martínez Macías CG
    Int Angiol; 2007 Dec; 26(4):378-84. PubMed ID: 18091707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Venous constriction by local administration of ruscus extract].
    Berg D
    Fortschr Med; 1990 Aug; 108(24):473-6. PubMed ID: 2227746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.
    Vanscheidt W; Jost V; Wolna P; Lücker PW; Müller A; Theurer C; Patz B; Grützner KI
    Arzneimittelforschung; 2002; 52(4):243-50. PubMed ID: 12040966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study).
    Guex JJ; Avril L; Enrici E; Enriquez E; Lis C; Taïeb C
    Int Angiol; 2010 Dec; 29(6):525-32. PubMed ID: 21173734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg.
    Tsouderos Y
    Int Angiol; 1989; 8(4 Suppl):53-9. PubMed ID: 2698902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences in the use of Essaven capsules in the treatment of venous leg diseases. Results of a double-blind study].
    Neumann-Mangoldt P
    Fortschr Med; 1979 Dec; 97(45):(2117-9). PubMed ID: 391678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of a phlebotonic agent].
    Thebault JJ
    Fortschr Med; 1983 Jul; 101(25):1206-12. PubMed ID: 6350133
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
    Geroulakos G; Nicolaides AN
    Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort).
    Allaert FA; Hugue C; Cazaubon M; Renaudin JM; Clavel T; Escourrou P
    Int Angiol; 2011 Jun; 30(3):272-7. PubMed ID: 21617611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg.
    Tsouderos Y
    Z Kardiol; 1991; 80 Suppl 7():95-101. PubMed ID: 1792820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conservative and surgical measures in phlebologic consulatation. Report on the potassium-neutral venous diuretic Dehydro-sanol-tri].
    Wissniowski T; Harlin-Wissniowski A
    Fortschr Med; 1974 Oct; 92(28):1132-7. PubMed ID: 4616896
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of Ruscus aculeatus extract, hesperidin methyl chalcone and ascorbic acid: a comprehensive review of their pharmacological and clinical effects and of the pathophysiology of chronic venous disease.
    Allaert FA
    Int Angiol; 2016 Apr; 35(2):111-6. PubMed ID: 26928296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the therapeutic effect of a phlebotropic drug with a new noninvasive method: rheography by reflected light].
    Tumino G; Berni A; Tromba L; Marignetti L
    Clin Ter; 1987 Aug; 122(3):189-94. PubMed ID: 2973911
    [No Abstract]   [Full Text] [Related]  

  • 19. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.
    Boyle P; Diehm C; Robertson C
    Int Angiol; 2003 Sep; 22(3):250-62. PubMed ID: 14612852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of horse-chestnut seed extract on transcapillary filtration in chronic venous insufficiency].
    Bisler H; Pfeifer R; Klüken N; Pauschinger P
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1321-9. PubMed ID: 3527643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.